The core principle of nano immunotherapy lies in the precise delivery of therapeutic agents. Nanoparticles can be engineered to carry immunomodulatory drugs, antigens, or genes that stimulate an immune response. These nanoparticles can be designed to target specific cancer cells, reducing off-target effects and enhancing the efficacy of the treatment.
